HomePVCT • OTCMKTS
add
Provectus Biopharmaceuticals Inc
Previous close
$0.076
Day range
$0.072 - $0.075
Year range
$0.045 - $0.15
Market cap
31.50M USD
Avg Volume
185.60K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 278.63K | 17.04% |
Operating expense | 874.88K | 2,374.96% |
Net income | -1.14M | -126.19% |
Net profit margin | -409.19 | -93.27% |
Earnings per share | — | — |
EBITDA | -976.45K | -264.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 390.44K | 2,064.87% |
Total assets | 666.26K | -38.25% |
Total liabilities | 5.74M | -32.75% |
Total equity | -5.07M | — |
Shares outstanding | 420.28M | — |
Price to book | -7.62 | — |
Return on assets | -292.05% | — |
Return on capital | 92.58% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.14M | -126.19% |
Cash from operations | -1.09M | -4.69% |
Cash from investing | — | — |
Cash from financing | 1.07M | 37.39% |
Net change in cash | -20.27K | 92.32% |
Free cash flow | -557.29K | 5.20% |
About
Founded
2002
Headquarters
Website
Employees
6
